We'll likely have to wait a while to see Firefly Aerospace's Alpha rocket take to the skies again. The first stage of the rocket that Firefly was prepping to make Alpha's seventh-ever flight exploded ...

Ra’anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced ...

The U.S. Federal Aviation Administration (FAA) has cleared Firefly Aerospace to resume launches of its Alpha rocket. The approval follows a months-long review of the failed "Message in a Booster" ...

Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association’s 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...

Share on Pinterest A common heart attack pill may not be helpful for some heart conditions, according to new research. Bibek Raj Giri/Getty Images Beta-blockers are a type of medication used after ...

Beta-blockers are a type of medication used after heart attacks. A recent study suggests that using beta-blockers does not improve certain outcomes after heart attacks where the left ventricular ...

A new major trial shows that beta-blockers don't provide any real benefit to people with the most common form of heart attack. Reading time: Reading time 3 minutes A common treatment given after heart ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

A major new analysis from the REBOOT (Treatment with Beta-blockers after Myocardial Infarction without Reduced Ejection Fraction) clinical trial, an international study coordinated by the Centro ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...

MADRID, Spain—Two randomized, controlled trials testing beta-blockers in post-MI patients without heart failure or impaired left ventricular ejection fraction added a bit of confusion to a field ...